CN108572255B - 检测pd-l1+循环肿瘤细胞的试剂在筛选癌症风险个体以及在癌症患者预后中的应用 - Google Patents

检测pd-l1+循环肿瘤细胞的试剂在筛选癌症风险个体以及在癌症患者预后中的应用 Download PDF

Info

Publication number
CN108572255B
CN108572255B CN201810210273.7A CN201810210273A CN108572255B CN 108572255 B CN108572255 B CN 108572255B CN 201810210273 A CN201810210273 A CN 201810210273A CN 108572255 B CN108572255 B CN 108572255B
Authority
CN
China
Prior art keywords
cancer
tumor cells
circulating tumor
ctcs
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201810210273.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN108572255A (zh
Inventor
曾如玉
陈嬿如
李佳萤
武立凡
王信翰
陈瑞麟
陈纯诚
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Micareo Taiwan Co ltd
Original Assignee
Micareo Taiwan Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micareo Taiwan Co ltd filed Critical Micareo Taiwan Co ltd
Publication of CN108572255A publication Critical patent/CN108572255A/zh
Application granted granted Critical
Publication of CN108572255B publication Critical patent/CN108572255B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G01N33/575—
    • G01N33/57595—
    • G01N33/5753—
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G01N33/492—Determining multiple analytes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G01N33/57535—
    • G01N33/57557—
    • G01N33/5759—

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Ecology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Physiology (AREA)
  • Transplantation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Hospice & Palliative Care (AREA)
CN201810210273.7A 2017-03-14 2018-03-14 检测pd-l1+循环肿瘤细胞的试剂在筛选癌症风险个体以及在癌症患者预后中的应用 Active CN108572255B (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201762471083P 2017-03-14 2017-03-14
US62/471,083 2017-03-14
US201762584634P 2017-11-10 2017-11-10
US62/584,634 2017-11-10

Publications (2)

Publication Number Publication Date
CN108572255A CN108572255A (zh) 2018-09-25
CN108572255B true CN108572255B (zh) 2023-05-16

Family

ID=61868129

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201810210273.7A Active CN108572255B (zh) 2017-03-14 2018-03-14 检测pd-l1+循环肿瘤细胞的试剂在筛选癌症风险个体以及在癌症患者预后中的应用

Country Status (8)

Country Link
US (1) US20180267046A1 (enExample)
EP (1) EP3376227B1 (enExample)
JP (1) JP2018155752A (enExample)
KR (1) KR20180105091A (enExample)
CN (1) CN108572255B (enExample)
AU (1) AU2018201819A1 (enExample)
CA (1) CA2998065A1 (enExample)
TW (1) TWI786095B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110142068B (zh) * 2019-06-12 2024-02-02 杭州华得森生物技术有限公司 一种上皮间质混合型循环肿瘤细胞检测试剂盒及方法
CN111551718A (zh) * 2020-04-20 2020-08-18 山东第一医科大学(山东省医学科学院) 一种检测前列腺癌患者外周血循环肿瘤细胞pd-l1表达的免疫荧光试剂盒及检测方法
CN111562375B (zh) * 2020-04-20 2022-05-06 山东第一医科大学(山东省医学科学院) 一种检测胃癌患者外周血循环肿瘤细胞pd-l1表达的免疫荧光试剂盒及检测方法
TWI874453B (zh) * 2020-09-17 2025-03-01 日商細胞雲股份有限公司 使用末稍血循環腫瘤細胞之解析的癌症治療方法
RU2738563C1 (ru) * 2020-09-18 2020-12-14 Ен Джун Чой Способ прогноза малигнизации и ранней диагностики злокачественных опухолей
CN120559253A (zh) * 2025-05-30 2025-08-29 中国医学科学院肿瘤医院 Pd-l1阳性循环肿瘤细胞在肝癌免疫治疗中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010096734A2 (en) * 2009-02-20 2010-08-26 John Wayne Cancer Institute B7-h3 antibody coupled bead assay for isolation and detection of circulating tumor cells in body fluids of melanoma and breast cancer patients
US20170242016A1 (en) * 2014-10-15 2017-08-24 Epic Sciences, Inc. Circulating tumor cell diagnostics for therapy targeting pd-l1

Also Published As

Publication number Publication date
JP2018155752A (ja) 2018-10-04
US20180267046A1 (en) 2018-09-20
TW201902534A (zh) 2019-01-16
EP3376227C0 (en) 2024-02-21
KR20180105091A (ko) 2018-09-27
EP3376227A1 (en) 2018-09-19
CN108572255A (zh) 2018-09-25
AU2018201819A1 (en) 2018-10-04
EP3376227B1 (en) 2024-02-21
CA2998065A1 (en) 2018-09-14
TWI786095B (zh) 2022-12-11

Similar Documents

Publication Publication Date Title
CN108572255B (zh) 检测pd-l1+循环肿瘤细胞的试剂在筛选癌症风险个体以及在癌症患者预后中的应用
Li et al. Clinical significance of circulating tumor cells and tumor markers in the diagnosis of lung cancer
Cauley et al. Circulating epithelial cells in patients with pancreatic lesions: clinical and pathologic findings
Kanda et al. Mutant TP53 in duodenal samples of pancreatic juice from patients with pancreatic cancer or high-grade dysplasia
Rink et al. Detection of circulating tumour cells in peripheral blood of patients with advanced non‐metastatic bladder cancer
Negin et al. Circulating tumor cells in colorectal cancer: past, present, and future challenges
Reddy et al. Pulmonary venous blood sampling significantly increases the yield of circulating tumor cells in early-stage lung cancer
Sawabata et al. Perioperative circulating tumor cells in surgical patients with non-small cell lung cancer: does surgical manipulation dislodge cancer cells thus allowing them to pass into the peripheral blood?
Baek et al. Clinical potential of circulating tumor cells in colorectal cancer: a prospective study
Koh et al. Heterogeneous expression of programmed death receptor-ligand 1 on circulating tumor cells in patients with lung cancer
Park et al. Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma
JP6485759B2 (ja) 末梢循環腫瘍細胞単位の悪性度の検出方法及びそのキット
Buscail et al. Tumor‐proximal liquid biopsy to improve diagnostic and prognostic performances of circulating tumor cells
Sawabata et al. Circulating tumor cells detected only after surgery for non-small cell lung cancer: is it a predictor of recurrence?
Li et al. Evaluation of sensitivity and specificity of CanPatrol™ technology for detection of circulating tumor cells in patients with non-small cell lung cancer
Li et al. Liquid biopsy in lung cancer
Tsai et al. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer
Chapman et al. Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers
Levy et al. Analysis of cell-free DNA to assess risk of tumoremia following endoscopic ultrasound fine-needle aspiration of pancreatic adenocarcinomas
Halawa et al. The role of liquid biopsy in the diagnosis and prognosis of WHO grade 4 astrocytoma
Nagaiah et al. Circulating tumor cells in the management of breast cancer
Mastronicola et al. Detection of disseminated tumor cells in aspirative drains after neck dissection
Liu et al. Value of circulating tumor cells in the diagnosis and treatment of solitary pulmonary nodules
He et al. A preliminary study of the clinical significance of folate receptor-positive circulating tumor cell in the management of hepatobiliary-pancreatic cancers
Feng et al. Clinical relevance of perioperative changes in circulating tumor cells in resectable colorectal cancer

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant